PDF) Unmasking Integration Challenges: The Case of Biogal's Acquisition by Teva Pharmaceutical Industries
Teva Reports First Quarter 2022 Financial Results
Bulgaria's Actavis to absorb Teva Pharmaceuticals Bulgaria
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.